• NPPA'S HELPLINE NO. 1800111255

435(E)

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 29th March, 2006)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

                                                                New Delhi, the 29th March, 2006

ORDER

S.O.435(E)  – In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 292(E), dated 29th March, 2000, S.O. 297(E) dated 29th March, 2001, S.O. 614(E) dated 29th June, 2001, S.O. 139(E) dated 31st January, 2002, S.O. 779(E) dated 22nd July, 2002, S.O. 1164(E) dated 20th October, 2004, S.O. 1351(E) dated 16th September, 2005, S.O. 17(E) dated 4th January, 2005 and S.O. 175(E) dated 7th February, 2006, in so far as it relates to formulation pack(s) mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority hereby fixes the prices as specified in column (5) of the table below as the ceiling price exclusive of excise duty, and local tax, if any, for scheduled formulation specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in column (3) and (4) thereof :

TABLE

Sl. No. Name of the Formulation Strength Pack Size Ceiling Price (Rs.)
(1) (2) (3) (4) (5)

--

Each tab. contains

--

1 Tablets of Ibuprofen +
Paracetamol & Others
Ibuprofen – 400 mg
Paracetamol – 325 mg
10’s Strip/Blister 5.96

NOTE :

(a)        For all the other tablet formulations containing Ibuprofen + Paracetamol with or without other active ingredients having composition different from contents mentioned in Column (3) of the above table, the following adjustment shall be made by a manufacturer to work out the maximum retail price (MRP) for a product under the said order for formulation (s) in column No. 2, when there is a change in the composition and the following factors (which are inclusive of admissible MAPE) shall be added / subtracted as the case may be to the notified ceiling price given in column No. 5 of the table on the following basis:

For each 10 tablets in strip / blister: :

1        For each 10 mg or part thereof of Ibuprofen Rs. 0.0819 shall be added / subtracted.

2        For each 10 mg or part thereof of Paracetamol Rs. 0.0363 shall be added / subtracted.

3        For each 10 mg or part thereof of Caffeine (Any) Rs. 0.1052 shall be added / subtracted.

4        For each 10 mg or part thereof of Magnesium Trisilicate Rs. 0.0089 shall be added / subtracted.

5        For each 5 mg or part thereof of Pseudoephedrine HCL Rs. 0.1949 shall be added / subtracted.

6        For each 1 mg or part thereof of Chlorpheniramine Maleate Rs. 0.0161 shall be added / subtracted.

7        For each 10 mg or part thereof of Chlorzoxazone Rs. 0.0941 shall be added / subtracted.

8        For each 10 mg or part thereof of Methacarbamol Rs. 0.1882 shall be added / subtracted.

9        For each 5 mg or part thereof of Dextropropoxyphene HCL Rs. 0.4258 shall be added / subtracted.

10        For each 10 mg or part thereof of Diclofenac Pottasium / Sodium Rs. 0.1007 shall be added / subtracted.

11        For each 1 mg or part thereof of Codeine Phosphate Rs. 0.7306 shall be added / subtracted.

12        For each 5 mg or part thereof of Baralgen Ketone Rs. 0.2721 shall be added / subtracted.

13        For each 0.1 mg or part thereof of Baralgen Amide Rs. 0.0435 shall be added / subtracted.

14        For each 1 mg or part thereof of Serratiopeptidose Rs. 0.2989 shall be added / subtracted.

(b)        The prices fixed are the maximum ceiling prices (exclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(c)        Pro-rata pricing for packs of same composition but of different sizes, will be applicable vide S.O. No. 83(E) dated 27.1.1998.

(d)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

PN/85/2006/F

F.No. 8(1)/2006/D.P./NPPA-Div.II

(A. K. PAL)
Deputy Director
National Pharmaceutical Pricing Authority

Last Page Updated: 07-06-2019